Results 151 to 160 of about 89,708 (258)

An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer. [PDF]

Nat Commun
Theophanous S, Lønne PI, Choudhury A, Berbee M, Deijen C, Dekker A, Field M, Gambacorta MA, Gilbert A, Grønlie Guren M, Jadon R, Kochhar R, Martin D, Mohamed AA, Muirhead R, Parés O, Raszewski Ł, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Vassiliou V, Malinen E, Wee L, Appelt A, atomCAT Consortium.   +25 more
europepmc   +1 more source

Homozygous Loss‐of‐Function Variant in SLC20A1 Coding for Ubiquitous Phosphate Transporter PiT1 Is Associated With Multiple Developmental Abnormalities

Clinical Genetics, Volume 110, Issue 1, Page 64-72, July 2026.
Biallelic SLC20A1 loss‐of‐function variant causes a previously unrecognized multisystem developmental disorder. We report the first homozygous case presenting with tetralogy of Fallot, renal agenesis, polydactyly, and growth impairment. Transcriptome analysis of patient‐derived fibroblasts suggests significant dysregulation of pathways critical for ...
Eugénie Koumakis, Céline Huber, Wendy Chung, Christine Leroy, Pauline Parisot, Regis Gaudin, Mohamad Zaidan, Valérie Cormier‐Daire, Gérard Friedlander, Yoel Hirsch   +9 more
wiley   +1 more source

Mucous Membrane Pemphigoid After Anti‐PD‐1 Therapy: Risk‐Stratified Management and Treatment Outcomes

International Journal of Dermatology, Volume 65, Issue 7, Page 1376-1382, July 2026.
ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Serena Dienes, Negar Esfandiari, Steven Daveluy   +2 more
wiley   +1 more source

Anti‐Black Racism in Nursing in Canada and Black Nurses' Resistance: An Analytic Review of Newspaper Coverage, 1940s–2020

Nursing Inquiry, Volume 33, Issue 3, July 2026.
ABSTRACT Black women's participation in nursing in Canada has been marked by a long history of discrimination and exclusion, even after they were formally permitted to enter the profession in the mid‐1940s. Examining mainstream Canadian newspaper coverage, this study traces anti‐Black racism in Canadian nursing from the 1940s to 2020.
Goldameir Oneka, Anne‐Emanuelle Birn
wiley   +1 more source

Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA. [PDF]

Cancers (Basel)
Kabarriti R, Lloyd S, Jabalee J, Gay LM, Slater T, Guzman K, Jacobs C, Inocencio S, Lin R, Nguyen C, MacEwan I, Crawford AH, Rutenberg M, Singh J, Ross J, Kim-Wang S, Matthiesen C, Neff K, Liu GF, Juarez TM, Liauw SL.   +20 more
europepmc   +1 more source

Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer

Cancer, Volume 132, Issue 12, 15 June 2026.
Abstract This literature‐based systematic review and associated guidelines provide evidence‐based paradigms for the management of locoregionally recurrent rectal cancer (LRRC). This multispecialty committee included gastrointestinal radiation and medical oncology, gastroenterology, radiology, and colorectal surgery.
Eric D. Miller, Krishan R. Jethwa, Eric Dozois, Zhaohui Jin, Gerard Abood, Dmitriy Akselrod, Joseph Attallah, D. Chamil Codipilly, Christopher J. Anker, Christopher L. Hallemeier, Leslie C. Hassett, Timothy Kennedy, Percy Lee, Diane C. Ling, Neil B. Newman, Navesh Sharma, William Small Jr., Leila Tchelebi, Suzanne Russo   +18 more
wiley   +1 more source

Detection of anal squamous dysplasia at routine colonoscopy in 121 patients: implications for anal cancer screening. [PDF]

Proc (Bayl Univ Med Cent)
Wu JS, Inkster MD.
europepmc   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, Volume 13, Issue 35, 24 June 2026.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Patient-reported outcomes after chemoradiotherapy for anal cancer. [PDF]

Acta Oncol
Slørdahl KS, Skovlund E, Olsen JÅ, Tvedt R, Thomsen M, Kaasa S, Guren MG.   +6 more
europepmc   +1 more source

Advances in Cancer Immunotherapy for Solid Tumors

Advanced Science, Volume 13, Issue 35, 24 June 2026.
Cancer immunotherapy for solid tumors is rapidly evolving beyond classical checkpoint blockade toward more precise strategies. Emerging checkpoint targets, bispecific antibodies, antibody–drug conjugate combinations, personalized vaccines, cellular therapies, and engineered cytokines are expanding therapeutic possibilities, while biomarker‐guided ...
Shira Gabizon‐Peretz, Harriet M. Kluger   +1 more
wiley   +1 more source